BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Egeberg A, Ashina M, Gaist D, Gislason GH, Thyssen JP. Prevalence and risk of migraine in patients with rosacea: A population-based cohort study. J Am Acad Dermatol 2017;76:454-8. [PMID: 27817869 DOI: 10.1016/j.jaad.2016.08.055] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Wienholtz N, Egeberg A, Thyssen JP. The many faces of rosacea: liberal diagnostic criteria have ramifications on disease prevalence and accuracy. J Eur Acad Dermatol Venereol 2019;33:e426-7. [PMID: 31199527 DOI: 10.1111/jdv.15748] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
2 Haber R, El Gemayel M. Comorbidities in rosacea: A systematic review and update. J Am Acad Dermatol 2018;78:786-792.e8. [PMID: 29107339 DOI: 10.1016/j.jaad.2017.09.016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 7.8] [Reference Citation Analysis]
3 Vera N, Patel NU, Seminario-vidal L. Rosacea Comorbidities. Dermatologic Clinics 2018;36:115-22. [DOI: 10.1016/j.det.2017.11.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
4 Wang FY, Chi CC. Association of rosacea with inflammatory bowel disease: A MOOSE-compliant meta-analysis. Medicine (Baltimore) 2019;98:e16448. [PMID: 31593075 DOI: 10.1097/MD.0000000000016448] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
5 Morss-Walton P, McGee JS. Rosacea, not just skin deep: Understanding thesystemic disease burden. Clin Dermatol 2021;39:695-700. [PMID: 34809774 DOI: 10.1016/j.clindermatol.2020.08.006] [Reference Citation Analysis]
6 Woo YR, Han YJ, Kim HS, Cho SH, Lee JD. Updates on the Risk of Neuropsychiatric and Gastrointestinal Comorbidities in Rosacea and Its Possible Relationship with the Gut-Brain-Skin Axis. Int J Mol Sci 2020;21:E8427. [PMID: 33182618 DOI: 10.3390/ijms21228427] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gallo RL, Granstein RD, Kang S, Mannis M, Steinhoff M, Tan J, Thiboutot D. Rosacea comorbidities and future research: The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol 2018;78:167-70. [PMID: 29102687 DOI: 10.1016/j.jaad.2017.06.150] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
8 Cribier B. [Rosacea: New data for better care]. Ann Dermatol Venereol 2017;144:508-17. [PMID: 28728857 DOI: 10.1016/j.annder.2017.06.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
9 Wienholtz NKF, Christensen CE, Haugaard JH, Zhang DG, Ashina M, Thyssen JP, Egeberg A. Cohort profile: COpenhagen ROsacea COhort (COROCO) and COpenhagen MIgraine COhort (COMICO). BMJ Open 2020;10:e039445. [PMID: 32819957 DOI: 10.1136/bmjopen-2020-039445] [Reference Citation Analysis]
10 Gether L, Overgaard LK, Egeberg A, Thyssen JP. Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol 2018;179:282-9. [PMID: 29478264 DOI: 10.1111/bjd.16481] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 10.3] [Reference Citation Analysis]
11 Oliveira CMM, Almeida LMC, Bonamigo RR, Lima CWG, Bagatin E. Consensus on the therapeutic management of rosacea - Brazilian Society of Dermatology. An Bras Dermatol 2020;95 Suppl 1:53-69. [PMID: 33172727 DOI: 10.1016/j.abd.2020.08.001] [Reference Citation Analysis]
12 Sinikumpu SP, Vähänikkilä H, Jokelainen J, Tasanen K, Huilaja L. Male patients with rosacea have increased risk for migraine: a population-based study. Br J Dermatol 2021;185:1058-61. [PMID: 34137465 DOI: 10.1111/bjd.20578] [Reference Citation Analysis]
13 Holmes AD, Spoendlin J, Chien AL, Baldwin H, Chang ALS. Evidence-based update on rosacea comorbidities and their common physiologic pathways. J Am Acad Dermatol 2018;78:156-66. [PMID: 29089181 DOI: 10.1016/j.jaad.2017.07.055] [Cited by in Crossref: 45] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
14 Thiboutot D, Anderson R, Cook-Bolden F, Draelos Z, Gallo RL, Granstein RD, Kang S, Macsai M, Gold LS, Tan J. Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol 2020;82:1501-10. [PMID: 32035944 DOI: 10.1016/j.jaad.2020.01.077] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
15 Egeberg A, Andersen YMF, Thyssen JP. Prevalence and characteristics of psoriasis in Denmark: findings from the Danish skin cohort. BMJ Open 2019;9:e028116. [PMID: 30898836 DOI: 10.1136/bmjopen-2018-028116] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
16 Petit A. [What's new in clinical dermatology?]. Ann Dermatol Venereol 2017;144 Suppl 4:IVS1-9. [PMID: 29249246 DOI: 10.1016/S0151-9638(17)31059-1] [Reference Citation Analysis]
17 Wienholtz N, Ashina M, Thyssen JP, Egeberg A. Subtype-Specific Off-Label Treatment of Rosacea. Case Rep Dermatol 2021;13:121-8. [PMID: 33790755 DOI: 10.1159/000511984] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Rainer BM, Kang S, Chien AL. Rosacea: Epidemiology, pathogenesis, and treatment. Dermatoendocrinol 2017;9:e1361574. [PMID: 29484096 DOI: 10.1080/19381980.2017.1361574] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 9.4] [Reference Citation Analysis]